One drug manufacturer has agreed to pay $10 million to resolve its part in allegations that Gilead and other drug makers conspired to keep HIV medication prices artificially high.
A Hawaii judge has ordered the makers of Plavix to pay $834 million for not providing adequate warning that the blood thinner may be ineffective for much of the state's…
The FDA has approved the use of a drug combination of Opdivo and Yervoy as a first-line treatment for mesothelioma.
A new class action lawsuit by an investor group accuses Gilead and other drug makers of antitrust law violations for preventing generic versions of HIV drugs.
Gilead and other drug manufacturers face a class action lawsuit claiming they conspired to keep generic HIV drugs off the market and to artificially inflate HIV drug prices.
A federal judge indicates parties have reached a global Abilify settlement agreement to resolve thousands of claims that the antipsychotic causes gambling addiction.
Six Abilify gambling addiction lawsuits are being fast-tracked through the discovery process for bellwether trials scheduled to begin next summer.
An Onglyza lawsuit claims the manufacturers hid the drug's risk of heart failure from the medical community.
A federal judge has remanded 21 Abilify gambling lawsuits back to California state courts, while nearly 2,000 cases move forward in the federal litigation.
A leading cancer researcher who failed to reveal deep industry ties and millions in payments has been ousted from a leading cancer center and sparked debate about the need for…
